國家衛生研究院 NHRI:Item 3990099045/6302
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 12145/12927 (94%)
造访人次 : 851072      在线人数 : 444
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧：
  • 您可在西文检索词汇前后加上"双引号"，以获取较精准的检索结果
  • 若欲以作者姓名搜寻，建议至进阶搜寻限定作者字段，可获得较完整数据
    •  进阶搜寻
    主页 ‧ 登入 ‧ 上传 ‧ 说明 ‧ 关于NHRI ‧ 管理 到手机版


    jsp.display-item.identifier=請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/6302


    题名: Genetic polymorphisms in the opioid receptor mu1 gene are associated with changes in libido and insomnia in methadone maintenance patients
    作者: Wang, SC;Tsou, HH;Chen, CH;Chen, YT;Ho, IK;Hsiao, CF;Chou, SY;Lin, YF;Fang, KC;Huang, CL;Su, LW;Fang, YC;Liu, ML;Wu, HY;Lin, KM;Liu, SC;Kuo, HW;Chiang, IC;Chen, AC;Tian, JN;Liu, YL
    贡献者: Division of Mental Health and Addiction Medicine;Division of Biostatistics and Bioinformatics;Division of Clinical Trial Statistics
    摘要: Methadone, a synthetic racemic opioid that primarily works as a mu-opioid receptor (OPRM1) agonist, is commonly used for the treatment of heroin addiction. Genetic association studies have reported that the OPRM1 gene is involved in the physiology of heroin and alcohol addiction. Our current study is designed to test the hypothesis that genetic polymorphisms in the OPRM1 gene region are associated with methadone dosage, plasma concentrations, treatment responses, adverse reactions and withdrawal symptoms in a methadone maintenance treatment (MMT) cohort from Taiwan. Fifteen OPRM1 single nucleotide polymorphisms (SNPs) were selected and genotyped using DNA samples from 366 MMT patients. The plasma concentrations of methadone and its metabolite were measured by high performance liquid chromatography. The results obtained using dominant model analysis indicate that the OPRM1 SNPs rs1074287, rs6912029, rs12209447, rs510769, rs3798676, rs7748401, rs495491, rs10457090, rs589046, rs3778152, rs563649, and rs2075572 are significantly associated with change-in-libido side effects (adjusted p<0.042). Using recessive model analysis, these SNPs were also found to be significantly associated with insomnia side effects in this cohort (p<0.009). The significance of the insomnia findings was mainly contributed by a subgroup of patients who had a positive urine morphine test (p<0.022), and by individuals who did not use benzodiazepine hypnotics (p<0.034). Our current data thus suggest that genetic polymorphisms in OPRM1 may influence the change-in-libido and insomnia side effects sometimes found in MMT patients.
    日期: 2012-10
    關聯: European Neuropsychopharmacology. 2012 Oct;22(10):695-703.
    Link to: http://dx.doi.org/10.1016/j.euroneuro.2012.02.002
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0924-977X&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000309781200002
    Cited Times(Scopus): http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84865565339
    显示于类别:[王聲昌] 期刊論文
    [鄒小蕙] 期刊論文
    [何英剛(2006-2011)] 期刊論文
    [蕭金福] 期刊論文
    [林克明(2004-2009)] 期刊論文
    [劉玉麗] 期刊論文

    文件中的档案:

    档案 描述 大小格式浏览次数
    PUB22406240.pdf385KbAdobe PDF723检视/开启


    在NHRI中所有的数据项都受到原著作权保护.

    TAIR相关文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈